HUB24 LIMITED — Director's Dealing 2023

Aug 31, 2023

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity HUB24 Limited ABN 87 124 891 685

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Andrew Alcock
Date of last notice	9 August 2023

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Direct interest
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.	N/A
Date of change	30thand 31stAugust 2023

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

No. of securities held prior to change

1,081,824 Fully Paid Ordinary Shares (FPO) 34,851 Performance rights to acquire fully paid shares issued 30 November 2016 (as per shareholder approval at the AGM held 29 November 2016). 23,897 Performance rights to acquire fully paid shares issued 11 December 2017 (as per shareholder approval at the AGM held 20 November 2017). 51,186 Options to acquire fully paid shares issued 12 December 2018 (as per shareholder approval at the AGM held 29 November 2018). 104,072 Performance rights to acquire fully paid shares issued 12 December 2018 (as per shareholder approval at the AGM held 20 November 2018). 54,764 Options to acquire fully paid shares issued 25 November 2019 (as per shareholder approval at the AGM held 19 November 2019). 21,932 Performance rights to acquire fully paid shares issued 25 November 2019 (as per shareholder approval at the AGM held 19 November 2019). 33,558 Options to acquire fully paid shares issued 24 December 2020 (as per shareholder approval at the AGM held 26 November 2020). 31,395 Performance rights to acquire fully paid shares issued 24 December 2020 (as per shareholder approval at the AGM held 26 November 2020). 270,000 Special performance rights to acquire fully paid shares issued 24 December 2020 (as per shareholder approval at the AGM held 26 November 2020). 35,901 Performance rights to acquire fully paid shares issued 23 December 2021 (as per shareholder approval at the AGM held 14 December 2021). 53,163 Performance rights to acquire fully paid shares issued 07 December 2022 (as per shareholder approval at the AGM held 16 November 2022).

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Number acquired		254,698 FPO - comprised from the exercise of 105,950 Options and 148,748 Performance Rights.
Number disposed		30 August 2023 250,000 FPO sold at $31.50 per FPO. 31 August 2023 Exercised 105,950 Options and 148,748 Performance Rights that have been converted to FPO as detailed in the above section.
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation		30 August 2023 Sale of 250,000 FPO at $31.50 per FPO. 31 August 2023 Exercise of 51,186 Options at $12.04 per Option. Exercise of 54,764 Options at $12.36 per Option. Exercise of 148,748 Performance Rights at Nil cost. FPO closing share price on 31.08.2023 was $32.28.

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3

Appendix 3Y Change of Director’s Interest Notice

No. of securities held after change

1,086,522 Fully Paid Ordinary Shares 14,072 Performance rights to acquire fully paid shares issued 12 December 2018 (as per shareholder approval at the AGM held 20 November 2018). 21,932 Performance rights to acquire fully paid shares issued 25 November 2019 (as per shareholder approval at the AGM held 19 November 2019). 33,558 Options to acquire fully paid shares issued 24 December 2020 (as per shareholder approval at the AGM held 26 November 2020). 31,395 Performance rights to acquire fully paid shares issued 24 December 2020 (as per shareholder approval at the AGM held 26 November 2020). 270,000 Special performance rights to acquire fully paid shares issued 24 December 2020 (as per shareholder approval at the AGM held 26 November 2020). 35,901 Performance rights to acquire fully paid shares issued 23 December 2021 (as per shareholder approval at the AGM held 14 December 2021). 53,163 Performance rights to acquire fully paid shares issued 07 December 2022 (as per shareholder approval at the AGM held 16 November 2022).

Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy- back

30 August 2023 – Sale of 250,000 FPO. 31 August 2023 – Exercise of 105,950 Options and 148,748 Performance Rights.

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	N/A as outlined above.
Nature of interest	N/A

• See chapter 19 for defined terms.

Appendix 3Y Page 4

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Name of registered holder (if issued securities)	N/A
Date of change	N/A
No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed	N/A
Interest acquired	N/A
Interest disposed	N/A
Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation	N/A
Interest after change	N/A

Part 3 –[+] Closed period

Part 3– +Closed period
Were the interests in the securities or contracts detailed above traded during a+closed period where prior written clearance was required?	No
If so, was prior written clearance provided to allow the trade to proceed during this period?	N/A
If prior written clearance was provided, on what date was this provided?	N/A

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 5